PBS NewsHour reports on the growing research into whether GLP-1 medications could help with addiction to alcohol and other drugs.
Recap by typeshit. Full story at PBS NewsHour.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
Visitors to Japan pay roughly a third of the Korean price for Mounjaro, and Korean customs says illegal imports of the drug are rising sharply this year.
Novo's preprint covers 10,052 trial patients and ties semaglutide to organ ages one to four years younger, but none of it is peer reviewed yet.
Loading…